Insiders Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Equities

OJU1

US68403P2039

Market Closed - Deutsche Boerse AG Other stock markets 07:04:45 10/05/2024 BST			5-day change	1st Jan Change
2.186 ^EUR	-1.44%		+1.11%	+4.54%

03-19	Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	CI
03-06	Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	03-19	CI
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	01-19	CI
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	12-19	CI
Oramed Pharmaceuticals Inc. Appoints Ben Shapiro to Its Board of Directors	01/05/23	CI
Insider Buy: Oramed Pharmaceuticals	15/03/23	MT
Insider Sell: Oramed Pharmaceuticals	04/01/23	MT
Oramed Pharmaceuticals Inc. Appoints Anne Peters to Its Scientific Advisory Board	01/06/22	CI
Oramed Pharmaceuticals Inc Announces Appoints Yadin Rozov to Its Board of Directors	04/04/22	CI
Oramed Pharmaceuticals Inc. Announces the Appointment of Netanel Derovan as Chief Legal Officer (General Counsel) and Company Secretary, Effective January 9, 2022	08/12/21	CI
Insider Sell: Oramed Pharmaceuticals	20/09/21	MT
Oramed Pharmaceuticals Inc. Appoints Michael Rabinowitz as Chief Commercial Officer	29/07/21	CI
Oramed Pharmaceuticals Inc. Appoints David Silberman as Treasurer and Secretary, Effective July 5, 2021	25/05/21	CI
Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Treasurer and Secretary Effective July 5, 2021	10/05/21	CI
Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Chief Financial Officer, Effective July 5, 2021	10/05/21	CI
Oramed Appoints Dr. Julio Rosenstock to its Scientific Advisory Board	30/01/20	CI
Oramed Pharmaceuticals Inc. Elects Alexander Fleming to Scientific Advisory Board	23/01/20	CI
Oramed Pharmaceuticals Inc. Appoints Jay Skyler to Scientific Advisory Board	21/01/20	CI
Oramed Appoints Arie Mayer to its Board of Directors	05/12/19	CI
Oramed Pharmaceuticals Inc. Appoints Joshua Hexter to Serve as Chief Operating & Business Officer, Effective September 19, 2019	21/08/19	CI
Oramed Pharmaceuticals Inc. Announces Board Changes	01/07/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Equities

OJU1

US68403P2039

Insiders

Filters